CROSS JOHN HARRY III (Chief Financial Officer) received a stock award from SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/22/2022ACC: 0001493152-22-036315
Officer· Chief Financial Officer
Since Apr 2020
+15.52K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
15.52K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15.52K
Price / share
—
Trade value
—
% of position
10.7%
12/14/2022
145.16K→160.68K
Total
Net shares
+15.52K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/14/2022 | A · Award | +15.52K | — | — | 10.7% | 145.16K | 160.68K |
| Total | +15.52K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported